Measurements of the photon and neutron dose delivered to organs outside the radiation beams for 3DCRT and IMRT radiotherapy A. Kowalik 1, W. Jackowiak.

Slides:



Advertisements
Similar presentations
10th Annual Lung Cancer Conference Radiation Oncology
Advertisements

Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Anatomy-based MLC Field Optimization for the Treatment of Gynecologic Malignancies Myriam Bouchard M.D. Nadeau S, Germain I, Raymond P.E., Harel F, Beaulieu.
Algorithms used in heterogeneous dose calculations show systematic error as measured with the Radiological Physics Center’s anthropomorphic thorax phantom.
Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland 8th ECMP, Athens, Dosimetry audits in radiotherapy.
Para-spinal Tumors Encircling the Spinal Cord IMRT Comparison of Several Target Definitions.
Radiation Dosimetry Dose Calculations D, LET & H can frequently be obtained reliably by calculations: Alpha & low – Energy Beta Emitters Distributed in.
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Volumetric Modulated Arc Therapy (VMAT)
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Introduction Modern radiation therapies such as intensity-modulated radiation therapy (IMRT) and volume modulated arc therapy (VMAT) demand from dose calculation.
Radiotherapy for Kidney cancer
Dose Distribution and Scatter Analysis
Results The measured-to-predicted dose ratio criteria used by the RPC to credential institutions is , however for this work, a criteria of
11. – , Athens 8th European Conference on Medical Physics DOSIMETRY AUDITS IN RADIOTHERAPY IN THE CZECH REPUBLIC Irena Koniarová Daniela Ekendahl.
TWO FIELD BREAST PLAN VS. OPTIMIZED CONFORMAL BREAST PLAN: COMPARISON OF PLAN PARAMETERS Authors: Borko Basarić, Ozren Čudić, Milan Teodorović, Borislava.
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
The external beam radiotherapy and Image-guided radiotherapy (2)
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Patient Plan Results: Table 3 shows the ratio of the Pinnacle TPS calculation to the DPM recalculation for the mean dose from selected regions of interest.
David Followill, Ph.D. Radiological Physics Center
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Radiation Protection in Radiotherapy
In vivo dosimetry Eirik Malinen Eva Stabell Bergstrand Dag Rune Olsen.
Surface dose prediction and verification for IMRT plans using line dose profiles † Ronald E. Berg, † Michael S. Gossman and ‡ Stephen J. Klash † Erlanger.
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
Application of a 2-D ionization chamber array for dose verification of dynamic IMRT with a micro-MLC Fujio ARAKI, PhD 1, S. TAJIRI 2, H. TOMINAGA 2, K.
The Radiological Physics Center’s Anthropomorphic Quality Assurance Phantom Program Carrie F. Amador, Nadia Hernandez, Andrea Molineu, Paola Alvarez, and.
Araki F. Ikegami T. and Ishidoya T.
Investigation of 3D Dosimetry for an Anthropomorphic Spine Phantom R. Grant 1,2, G. Ibbott 1, J. Yang 1, J. Adamovics 3, D Followill 1 (1)M.D. Anderson.
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
Introduction The Radiological Physics Center (RPC) anthropomorphic quality assurance (QA) phantom program is one tool the RPC uses to remotely audit institutions.
Optimization of Volumetric Modulated Arc Therapy (VMAT) Planning Strategy Using Ring-shaped ROI for Localized Prostate cancer Kentaro Ishii, Masako Hosono,
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
Photoneutron Distributions around 18 MV X-ray Radiotherapy Accelerators using Nuclear Track Detectors Fazal-ur-Rehman, H. Al-Ghamdi, M. I. Al-Jarallah.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
第三讲: Basic treatment planning - Dengsong Zhu, MS, DABR Medical Physicist Radiation Safety Officer.
Rapid Arc Treatment Verification: post evaluation on Delta-4 and proposal of a new verification protocol G. Pittomvils 1,,L. Paelinck 1, T. Boterberg 1,
Retroactive Calculation of TLD and Film Dose in Anthropomorphic Phantom as Assessment of Updated TPS Performance H. Alkhatib 1, S. Oves 1, B. Tsang 1,
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
A. Sánchez-Reyes. , N. López Vilanova+, A. Vila. , M. A. Duch+, A
Electron Beam Therapy.
Introduction Materials & Methods Results Conclusion
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Introduction and Objectives
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity- modulated radiation therapy and volumetric modulated arc therapy.
CONTACT Catalina A. Riley
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
VMAT-technique (volumetric modulated arc therapy), IMRT-technique (intensity modulated radiotherapy) and 3D-conformal radiation for Lymphomas in Radiation.
Neuroaxis Radiation for pediatric tumors (Medulloblastoma and Atypical teratoid/rhabdoid tumor) with VMAT (volumetric modulated arc therapy) and IMRT (intensity.
Insert tables Insert figure
Insert tables Insert graphs Insert figure
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Conformal Photon-Beam Radiotherapy of Prostate Carcinoma
Insert tables Insert graphs Insert figure
Radiation Oncology Department, Bank of Cyprus Oncology Center.
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD.
Figure 4 Dosimetric comparison of LDR‑BT versus HDR‑BT
Figure 2 Nonmalignant tissue can be spared from radiation
Chapter 17 Intensity-Modulated Radiation Therapy
Technical Innovations and Patient Support in Radiation Oncology
Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques 
GHG meeting at ESTRO36 May, 2017
Surface doses of flattening filter free beams with volumetric modulated arc therapy dose delivery for breast cancer  Jan Seppälä, Aleksi Voutilainen,
Average Dose-Volume Ratio
Presentation transcript:

Measurements of the photon and neutron dose delivered to organs outside the radiation beams for 3DCRT and IMRT radiotherapy A. Kowalik 1, W. Jackowiak 2, J. Malicki 1,3, M. Skórska 1, M. Adamczyk 1, E. Konstanty 1, T. Piotrowski 1,3, K. Polaczek – Grelik 4 1. Dep. of Medical Physics, Greater Poland Cancer Centre, Garbary 15, Poznan, Poland, phone , 2. Dep. Of Radiotherapy,` Greater Poland Cancer Centre, Garbary 15, Poznan, Poland 3. Dep. of Electroradiology, University of Medical Sciences, Poznan, Poland 4. Dep. of Medical Physics, University of Silesia, Uniwersytecka 4, Katowice, Poland Introduction: Nowadays, there are many modern techniques of radiotherapy: IMRT (Intensity Modulated Radiotherapy), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Radiation Therapy (SRS) etc. Rapid development of technology in radiotherapy introduced tools that allow more homogenous dose in the target but may cause dose increase outside the target. The IMRT technique provides more homogenous dose in the target than 3DCRT but the dose delivered to organs at risk during treatment can be bigger than during 3DCRT delivery. Estimation of doses outside the PTV from all sources is necessary to assess total stochastic risks and thus provide adequate justification of the exposures as required by International Commission on Radiological Protection (ICRP). Materials and methods: The doses in organ at risk (OAR) outside the target: thyroid, lung, bladder and testes were measured in the anthropomorphic Alderson phantom using thermoluminescence detectors TLD 100 ( 6 Li (7.5%) and 7 Li (92.5%); (Harshaw Chemical Company). Subsequently, the prostate (Clinical Target Volume: CTV1), nodes (CTV2) and organs at risk (bladder, rectum, femoral heads, lung, thyroid and testes) were contoured. The target consists of the whole pelvic lymph nodes and the prostate gland with seminal vesicles. In the next stage three treatment plans were calculated for three alternative techniques: 3DCRT, IMRT and Tomotherapy. For organs which were inside or close to the treatment fields the doses were read from Treatment Planning System (TPS), i.e. rectum, bladder and testes. However, the readout of the doses for the thyroid and lung from the treatment planning system was impossible because commercial systems do not calculate doses at such a long distances outside the target volume. The thickness of each layer in the Alderson phantom is 2.5 cm and the distance between dosimetric points is 3 cm which allows for an accurate determination of the doses in chosen organs. Additionally, the neutron fluence rate [cm- 2s-1] at chosen points inside the same phantom was measured in terms of neutron activation analysis (NAA) with the use of gold which have 0.5 cm of diameter and the mean surface density of g/cm3. Purpose: To check the doses from photon beam irradiation of prostate cancer and from scattered neutrons in organs at risk (OARs) for static fields and IMRT. Conclusions: However for IMRT technique the doses were lower only for the bladder compared with 3DCRT. The surprise for IMRT was that for this technique the doses were lower only for the bladder compared with 3DCRT. The present investigation shows that photoneutron dose (resulting from the use of high-energy X-ray beam) constitutes about 0.5% of the therapeutic dose prescribed in PTV. Literature: 1. Al-Ghamdi H., Fazal-ur-Rehman, Al-Jarallah M.I., Maalej N., Photoneutron intensity with field size around radiotherapy linear accelerator 18-MeV X-ray beam, Radiation Measurements 43: S495– S499, Chibani O., Ma Ch-M.Ch., Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs, Medical Physics 30(8): 1990–2000, Francois P., Beurtheret C., DutreixA., Calculation of the dose delivered to organs outside the radiation beams, Medical Physics, 15(6), , Howell R.M., Scarboro S.B., Kry S.F., Yaldo D.Z., Accuracy of out- of-field dose calculations by a commercial treatment planning system, Physics in Medicine and Biology, Dec7; 55(23): , Hall EJ, Wuu C: Radiation-induced second cancers: the impact of 3D-CRT and IMRT, International Journal of Radiation Oncology, Biology and Physics, 56:83-88, Harrison RM, Wilkinson M, Shemilt A, Rawlings DJ, Moore M, Lecomber AR. Estimating second cancer risk following radiotherapy: organ doses from prostate radiotherapy and concomitant exposures, Biomedizinishe Technik, 50(Suppl. vol 1 Part 1):768–9, Results: The doses for particular organs measured during 3DCRT treatment were: thyroid gland – 0.62Gy, lung – 0.99Gy, bladder – 80.61Gy, testes – 4.38Gy; during IMRT treatment: thyroid gland – 2.88Gy, lung – 4.78Gy, bladder – 53.75Gy, testes – 6.48Gy. In the case where the neutron dose was measured, the neutron dose (resulting in the use of high-energy X-ray beam) constituted about 0.5% of the therapeutic dose prescribed in PTV. The further from the field edge the higher the contribution of this secondary radiation dose (from 8% to ~45%). localization IMRT3DCRTTomotherapy mean dose [Gy] thyroid 2.88 ± ± ± lung 4.76 ± ± ± bladder ± ± ± testes 6.48 ± ± ± Localization Effective dose [mSv/Gy] Total neutron effective dose normalized to 76 Gy in PC [mSv] Mean normalized dose [mSv] in organ Slow neutrons Fast neutrons Pelvis – right side ± ± ± Pelvis – left side ± ± ± Right lung – the corner ± ± ± Left lung – the corner ± ± ± Right lung – the center ± ± ± Left lung – the center ± ± ± Right lung – the top ± ± ± Left lung – the top ± ± ± Right eye ± ± ± Left eye ± ± ± a)b) Fig. 1. Tomotherapy (a), 3DCRT (b) and IMRT (c) plan for anthropomorphic phantom for prostate with nodes case. Table 2. The results of measurements out of the field of irradiation for 3DCRT, IMRT and Tomotherapy. Table 3. The effective neutron dose estimated out of the field of irradiation for IMRT prostate radiotherapy. Figure 3. The distribution of neutron fluence during prostate IMRT normalized to 1 Gy of dose in PTV on the left side (a) and on the right side (b) of the anthropomorphic phantom. The slow ( ■ ) and the fast ( ■ ) components are separated, showing the decrease of total neutron fluence when the distance from the isocentre is increased. a) b)c)